biosimilars | pharmaphorum

Sunday 20 September 2026

biosimilars

News

FDA approve Rituxan

Celltrion's Rituxan biosimilar gets glowing review ahead of ...

Reviewers from the FDA have given Celltrion’s biosimilar of Roche’s blood cancer blockbuster Rituxan a glowing report ahead of a key meeting of its advisers tomorrow.

News

Merck & Co signs biosimilars deal for US veterans

Merck & Co signs biosimilars deal for US veterans

Merck & Co has signed a deal with the US Department of Veterans Affairs (VA) for its inflammatory diseases biosimilar, Renflexis, so that veterans’ care can be improved.

News

Pfizer CEO Read to step down, COO Bourla takes the helm

Pfizer CEO Read to step down, COO Bourla takes the helm

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla.

Partner Content

300x300-Biosimilars-USA

Partner Content

SMi’s release speaker interview Anita Burrell, speaker at Bi...

Biosimilars USA conference information

News

celltrion

Celltrion hopes to outdo inflammatory disease rivals with SC...

Drugmaker could file in EU in coming weeks, according to report

Partner Content

300x300-Biosimilars-USA

Partner Content

FDA releases Biosimilar Action Plan: Hear more at Biosimilar...

Biosimilars USA conference information